Skip to main content

Table 8 Summary of published data from tumor MMR analysis from suspected Latin America LS families

From: A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America

Latin America published data

Number of families

Number of individuals

Clinical criteria

MMR deficient (%)

MMR non-deficient (%)

Loss IHC

 

MSI

AMSII

Revised Bethesda

Other criteria

MLH1 (%)

PMS2 (%)

MSH2 (%)

MSH6 (%)

PMS1 or MSH3* (%)

MSI-H (%)

MSS (%)

Medellin, Colombia [16]

41

41

4

27

10

14 (34.1)

27 (65.9)

na

na

na

na

na

14 (34.1)

27 (65.9)

Rosario Santa Fe, Argentina [14]

1

3

1

na

na

1 (33.3)

2 (66.7)

na

na

na

na

na

1 (33.3)

2 (66.7)

Sao Paulo, Brazil [15]

106

106

na

na

na

14 (13.2)

92 (86.8)

na

na

na

na

na

14 (13.2)

91 (85.9)

Buenos Aires, Argentina [18]

41

40

16

0

25

18 (45)

22 (55)

12 (30)

na

7 (17.5)

na

na

13 (32.5)

17 (42.5)

Minas Gerais, Brazil [22]

66

66

8

15

43

15 (22.7)

51 (77.3)

na

na

na

na

na

15 (22.7)

51 (77.3)

San Juan, Puerto Rico [21]

164

164

na

na

na

7 (4.3)

157 (95.7)

1 (0.06)

na

6 (3.7)

na

na

1 (0.6)

na

Lima, Peru [24]

90

90

na

na

na

35 (38.9)

55 (61.1)

23 (25.6)

18 (20)

4 (4.4)

2 (2.2)

na

26 (28.9)

64 (71.1)

Rio Grande do Sul, Brazil [25]

212

197

22

100

0

42 (21.3)

155 (78.7)

na

na

na

na

na

42 (21.4)

155 (78.7)

Mexico City, Mexico [27]

10

6

0

5

1

2 (33.3)

4 (66.7)

2 (33.3)

na

0

na

na

na

na

Minas Gerais, Brazil [28]

77

77

10

17

10

16 (20.8)

61 (79.2)

na

na

na

na

na

16 (20.8)

61 (79.2)

Santiago, Chile [31]

35

35

19

16

na

21 (60)

14 (40)

21 (60)

0

6 (17.1)

4 (11.4)

na

28 (80)

7 (20)

Lambayeque, Peru [35]

5

3

5

0

na

1 (33.3)

2 (66.7)

1 (33.3)

1 (33.3)

0

0

na

1 (33.3)

0

Sao Paulo, Brazil [37]

118

118

9

52

57

3 (2.5)

115 (97.5)

3 (2.5)

3 (2.5)

5 (4.2)

5 (4.2)

na

12 (10.2)

na

Santo Andre, SP, Brazil [43]

48

48

2

na

17

13 (27.1)

35 (72.9)

2 (4.2)

3 (6.3)

0

2 (4.2)

9 (19)

na

na

Lima, Peru [45]

28

28

0

0

28

11 (39.3)

17 (60.7)

na

na

na

na

na

11 (39.3)

17 (60.7)

Total

1042

1022

96

232

191

213 (20.8)

809 (79.2)

65 (46.4)

25 (17.9)

28 (20)

13 (9.3)

9 (6.4)

168 (36.9)

287 (63.1)

  1. MMR mismatch repair, MSI microsatellite instabily, MSI-H MSI-high, MSS microsatellite stable; na not applied, SD standard deviation, IHC immunohistochemistry